Insights

Case Studies & Regulatory Perspective

How compliance science moves projects from validation to industrialization — and the policy shifts shaping the path.

Case Studies

From the Platform

Case Study · GLP
From safety evaluation to market approval, without the usual 18-month wait
Organ-chip prescreening + integrated GLP took a cardiovascular device to NMPA registration in 12 months.
Read more
Case Study · Organoid Validation
When traditional animal models can't capture how a new biomaterial really behaves
Organ-chip prediction gave an early-stage biomaterials company a faster, more defensible evaluation path.
Read more
Policy Watch

Regulatory & Industry Perspective

Policy Watch
China's 2026 regulatory reform: what it means for GLP and CDMO timelines
Faster clinical trial review and new rare-disease device pathways, explained.
Read more
Policy Watch
Surgical robotics & high-end device localization: where CDMO capacity becomes the bottleneck
Why process-transfer capacity — not R&D — is the real constraint as precision requirements climb.
Read more
Have a project to discuss?
Let's talk about where your project stands and how the platform can help
See the Platform ArchitectureContact Us
↑